NASDAQ:LQDA

Liquidia Stock Forecast, Price & News

$2.78
-0.01 (-0.36 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.71
$2.79
50-Day Range
$2.28
$2.81
52-Week Range
$2.25
$5.95
Volume204,354 shs
Average Volume723,478 shs
Market Capitalization$144.49 million
P/E RatioN/A
Dividend YieldN/A
Beta0.08
30 days | 90 days | 365 days | Advanced Chart
Receive LQDA News and Ratings via Email

Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter.


Liquidia logo

About Liquidia

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The company was founded on June 28, 2020 and is headquartered in Morrisville, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.88 out of 5 stars

Medical Sector

686th out of 1,351 stocks

Surgical & Medical Instruments Industry

70th out of 123 stocks

Analyst Opinion: 3.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Liquidia (NASDAQ:LQDA) Frequently Asked Questions

Is Liquidia a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Liquidia stock.
View analyst ratings for Liquidia
or view top-rated stocks.

What stocks does MarketBeat like better than Liquidia?

Wall Street analysts have given Liquidia a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Liquidia wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Liquidia's next earnings date?

Liquidia is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Liquidia
.

How were Liquidia's earnings last quarter?

Liquidia Co. (NASDAQ:LQDA) issued its earnings results on Monday, August, 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.16) by $0.03.
View Liquidia's earnings history
.

How has Liquidia's stock price been impacted by Coronavirus (COVID-19)?

Liquidia's stock was trading at $3.66 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LQDA stock has decreased by 24.3% and is now trading at $2.77.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for LQDA?

3 analysts have issued 12 month price objectives for Liquidia's shares. Their forecasts range from $4.00 to $6.00. On average, they expect Liquidia's share price to reach $5.00 in the next year. This suggests a possible upside of 80.5% from the stock's current price.
View analysts' price targets for Liquidia
or view top-rated stocks among Wall Street analysts.

Who are Liquidia's key executives?

Liquidia's management team includes the following people:
  • Damian deGoa, Chief Executive Officer & Director
  • Robert A. Lippe, Chief Operating Officer
  • Michael Kaseta, Chief Financial Officer
  • Tushar Shah, Chief Medical Officer
  • Scott Moomaw, Senior Vice President-Commercial

What other stocks do shareholders of Liquidia own?

When did Liquidia IPO?

(LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

What is Liquidia's stock symbol?

Liquidia trades on the NASDAQ under the ticker symbol "LQDA."

Who are Liquidia's major shareholders?

Liquidia's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.90%), Millennium Management LLC (2.14%), Ikarian Capital LLC (1.71%), BlackRock Inc. (1.63%), Morgan Stanley (0.75%) and Morgan Stanley (0.75%). Company insiders that own Liquidia stock include Eshelman Ventures, Llc, Paul B Manning and Russell Schundler.
View institutional ownership trends for Liquidia
.

Which institutional investors are selling Liquidia stock?

LQDA stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Northern Trust Corp, Geode Capital Management LLC, Bank of New York Mellon Corp, Susquehanna International Group LLP, Ikarian Capital LLC, and Citadel Advisors LLC.
View insider buying and selling activity for Liquidia
or view top insider-selling stocks.

Which institutional investors are buying Liquidia stock?

LQDA stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Vanguard Group Inc., Millennium Management LLC, Renaissance Technologies LLC, Deutsche Bank AG, Tibra Equities Europe Ltd, and Ergoteles LLC. Company insiders that have bought Liquidia stock in the last two years include Eshelman Ventures, Llc, Paul B Manning, and Russell Schundler.
View insider buying and selling activity for Liquidia
or or view top insider-buying stocks.

How do I buy shares of Liquidia?

Shares of LQDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Liquidia's stock price today?

One share of LQDA stock can currently be purchased for approximately $2.77.

How much money does Liquidia make?

Liquidia has a market capitalization of $143.97 million and generates $740,000.00 in revenue each year. The company earns $-59,760,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis.

How many employees does Liquidia have?

Liquidia employs 51 workers across the globe.

What is Liquidia's official website?

The official website for Liquidia is www.liquidia.com.

Where are Liquidia's headquarters?

Liquidia is headquartered at 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560.

How can I contact Liquidia?

Liquidia's mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 328-4400 or via email at [email protected].


This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.